Cadrenal Therapeutics, Inc. Common Stock (CVKD)
US$ 17.73998.9%
Price Chart
Key Statistics
Market Cap
$ 31.85M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
91.76K
52W High
$ 22.90
52W Low
$ 5.70
Dividend Yield
0.00%
Beta
1.46
Technicals
50-Day MA
17.5823
200-Day MA
14.1005
52 Week High
22.9011
52 Week Low
5.7
About CVKD
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.
Employees
4
Headquarters
Ponte Vedra, FL
CEO
Mr. Quang X. Pham
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg